Drug Shows Promise For Fragile X

 New research suggests that medication could bring about significant improvements in cognitive function and language in adults with fragile X syndrome, the most common cause of inherited intellectual disability. Read More >

Cancer Drug May Play Role In Treating Fragile X

A potential cancer treatment may also relieve behavioral symptoms of a condition associated with autism and intellectual disability, researchers say.  http://www.disabilityscoop.com/2014/12/02/cancer-drug-fragile-x/19883/

Clinical trial shows promising treatment for fragile X, Autism

A new drug compound known as STX 209, or Arbaclofen, is showing promise for treating some of the symptoms of fragile X syndrome and some types of autism. A clinical trial involving patients ages 6 to 39 with fragile X showed some improvement in social withdrawal and other challenging behaviors. "This is the first large-scale study that is based on the molecular understanding of fragile X syndrome and, importantly, suggests that the core symptoms may be amenable to pharmacologic treatment," the study's lead author, Elizabeth Berry-Kravis of Rush University Medical Center, said. Disability Scoop (9/20)  http://www.disabilityscoop.com/2012/09/20/drug-treat-fragile-autism/16484/